The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Open accessAbstract
We analysed whole-genome sequences of 560 breast cancers to advance understanding of the driver mutations conferring clonal advantage and the mutational processes generating somatic mutations. We found that 93 protein-coding cancer genes carried probable driver mutations. Some non-coding regions exhibited high mutation frequencies, but most have distinctive structural features probably causing elevated mutation rates and do not contain driver mutations. Mutational signature analysis was extended to genome rearrangements and revealed twelve base substitution and six rearrangement signatures. Three rearrangement signatures, characterized by tandem duplications or deletions, appear associated with defective homologous-recombination-based DNA repair: one with deficient BRCA1 function, another with deficient BRCA1 or BRCA2 function, the cause of the third is unknown. This analysis of all classes of somatic mutation across exons, introns and intergenic regions highlights the repertoire of cancer genes and mutational processes operating, and progresses towards a comprehensive account of the somatic genetic basis of breast cancer. Whole-genome sequencing of tumours from 560 breast cancer cases provides a comprehensive genome-wide view of recurrent somatic mutations and mutation frequencies across both protein coding and non-coding regions; several mutational signatures in these cancer genomes are associated with BRCA1 or BRCA2 function and defective homologous-recombination-based DNA repair. This study reports whole-genome sequencing of tumours and normal tissue from 560 breast cancer cases, providing a comprehensive genome-wide view of recurrent somatic mutations and mutation frequencies across both protein coding and non-coding regions. The authors analyse mutational signatures in these cancer genomes, including a new investigation of rearrangement mutational processes, and find several that are associated with BRCA1 or BRCA2 function and defective homologous-recombination-based DNA repair. They also find mutational signatures showing distinct DNA replication strand biases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, BRCA inactivation is known to promote genomic instability through homologous recombination deficiencies in several solid tumors such as breast and ovarian cancer.47”
From Evolution of Multiple Myeloma from a Genomic Perspective (2026) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, some mutational footprints were found to be associated with BRCA1/2 deficiency, namely deletions with flanking microhomology, as well as several “mutational signatures” including two COSMIC single nucleotide variant (SNV) signatures and two structural variant (SV) signatures8.”
From Pan-cancer landscape of homologous recombination deficiency. (2020) · cites this paper as [8]
In the citing paper
“These genomic features in the SCAN-B TNBC cohort were comparable to a previously reported WGS cohort8”
From Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study (2019) · cites this paper as [8]
In the citing paper
“Five substitution and five rearrangement signatures [8, 9] were identified”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Seventy-nine out of the 93 previously identified BC driver genes [9] were mutated”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Despite the role of TP53, ATM and CHEK2 in DNA-damage signalling and double-strand breaks detection, these tumours do not show evidence of BRCA-deficient signatures, as previously described [9, 13, 19], but instead they harbour highly complex clustered chromosomal rearrangements.”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“The variant was not reported in gnomAD or in the 560 BC genomes cohort [9] and is described by ClinVar (Variation ID: 135816) as ‘Class 3 Uncertain significance’”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Loss of function of BRCA1, BRCA2 and PALB2 yield a high mutation burden and specific signatures inferring defective HR [7, 9, 10, 13].”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“These clustered events coincided with amplifications of known BC oncogenes (e.g. ZNF217, ERBB2, CCND1, MYC) [9]”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Self-citationNishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Self-citationVelvet: Algorithms for de novo short read assembly using de Bruijn graphsPreprint
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,575
Self-citationThe genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Self-citationConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,645
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Cited by
Sorted by citations
Items 201–300 of 1,002
Wang, S., Li, H., Song, M., He, Z., Wu, T., Wang, X., Tao, Z., Wu, K., & Liu, X. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009557 · Cited by 141
Single-cell genomic variation induced by mutational processes in cancer
Funnell, T., O’Flanagan, C. H., Williams, M. J., McPherson, A., McKinney, S. E., Kabeer, F., Lee, H., Salehi, S., Vázquez-Garćıa, I., Shi, H., et al. (2022) · Nature · doi:10.1038/s41586-022-05249-0 · Cited by 139
Self-citationFang, L. T., Zhu, B., Zhao, Y., Chen, W., Yang, Z., Kerrigan, L., Langenbach, K. J., de Mars, M., Lu, C., Idler, K. B., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00993-6 · Cited by 129
de Jong, V. M. T., Wang, Y., ter Hoeve, N. D., Opdam, M., Stathonikos, N., Jóźwiak, K., Hauptmann, M., Cornelissen, S., Vreuls, W., Rosenberg, E. H., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.01536 · Cited by 151
Self-citationDetection of early seeding of Richter transformation in chronic lymphocytic leukemia
Nadeu, F., Royo, R., Massoni-Badosa, R., Playà-Albinyana, H., García-Torre, B., Duran‐Ferrer, M., Dawson, K. J., Kulis, M., Díaz‐Navarro, A., Villamor, N., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01927-8 · Cited by 140
Self-citationMechanism of tandem duplication formation in BRCA1-mutant cells
Willis, N. A., Frock, R. L., Menghi, F., Duffey, E. E., Panday, A., Camacho, V., Hasty, P., Liu, E. T., Alt, F. W., & Scully, R. (2017) · Nature · doi:10.1038/nature24477 · Cited by 143
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencingPreprint
Cortés‐Ciriano, I., Lee, J. J.-K., Xi, R., Jain, D. S., Jung, Y. L., Yang, L., Gordenin, D. A., Klimczak, L. J., Zhang, C., Pellman, D. S., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/333617 · Cited by 137
Self-citationMutational Signatures in Breast Cancer: The Problem at the DNA Level
Nik‐Zainal, S., & Morganella, S. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2810 · Cited by 139
Self-citationTemplated Insertions: A Smoking Gun for Polymerase Theta-Mediated End Joining
Schimmel, J., van Schendel, R., den Dunnen, J. T., & Tijsterman, M. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.06.001 · Cited by 134
Molecular subtypes and precision treatment of triple-negative breast cancer
Zhao, S., Zuo, W., Shao, Z., & Jiang, Y. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.194 · Cited by 140
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways
Steele, C. D., Tarabichi, M., Oukrif, D., Webster, A. P., Ye, H., Fittall, M. W., Lombard, P., Martincorena, I., Tarpey, P. S., Collord, G., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.02.002 · Cited by 131
Self-citationEmerging roles of spliceosome in cancer and immunity
Yang, H., Beutler, B., & Zhang, D. (2021) · Protein & Cell · doi:10.1007/s13238-021-00856-5 · Cited by 135
Extrachromosomal DNA amplifications in cancer
Yi, E. S., González, R. C., Henssen, A. G., & Verhaak, R. G. W. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00521-5 · Cited by 131
Variant classification in precision oncology
Leichsenring, J., Horak, P., Kreutzfeldt, S., Heining, C., Christopoulos, P., Volckmar, A., Neumann, O., Kirchner, M., Ploeger, C., Budczies, J., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32358 · Cited by 131
Arruabarrena-Aristorena, A., Maag, J. L. V., Kittane, S., Cai, Y., Karthaus, W. R., Ladewig, E., Park, J., Kannan, S., Ferrando, L., Cocco, E., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.08.003 · Cited by 130
Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids
Prince, E., Cruickshank, J., Ba-Alawi, W., Hodgson, K., Haight, J., Tobin, C., Wakeman, A., Avoulov, A., Topolskaia, V., Elliott, M. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28788-6 · Cited by 135
Głodzik, D., Bosch, A., Hartman, J., Aine, M., Vallon‐Christersson, J., Reuterswärd, C., Karlsson, A., Mitra, S., Niméus, E., Holm, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17537-2 · Cited by 137
Self-citationNon-coding driver mutations in human cancer
Elliott, K., & Larsson, E. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00371-z · Cited by 137
The landscape of somatic genetic alterations in breast cancers from ATM germline mutation carriers
Weigelt, B., Bi, R., Kumar, R., Blecua, P., Mandelker, D. L., Geyer, F. C., Pareja, F., James, P. A., kConFab Investigators, Couch, F. J., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy028 · Cited by 128
Analysis of somatic microsatellite indels identifies driver events in human tumors
Maruvka, Y. E., Mouw, K. W., Karlić, R., Parasuraman, P., Kamburov, A., Polak, P. P., Haradhvala, N. J., Hess, J. M., Rheinbay, E., Brody, Y., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3966 · Cited by 126
Capture Hi-C identifies putative target genes at 33 breast cancer risk loci
Baxter, J. S., Leavy, O. C., Dryden, N. H., Maguire, S. L., Johnson, N., Fedele, V., Simigdala, N., Martin, L., Andrews, S., Wingett, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03411-9 · Cited by 123
Picco, G., Chen, E. D., García‐Alonso, L., Behan, F. M., Gonçalves, E., Bignell, G. R., Matchan, A., Fu, B., Banerjee, R., Anderson, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09940-1 · Cited by 128
Self-citationWen, W. X., & Leong, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215381 · Cited by 129
Póti, Á., Gyergyák, H., Németh, E., Rusz, O., Tóth, S., Kovácsházi, C., Chen, D., Szikriszt, B., Spisák, S., Takeda, S., et al. (2019) · Genome Biology · doi:10.1186/s13059-019-1867-0 · Cited by 116
Self-citationBayesian inference of negative and positive selection in human cancers
Weghorn, D., & Sunyaev, S. R. (2017) · Nature Genetics · doi:10.1038/ng.3987 · Cited by 120
GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential
Mulligan, L. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01873 · Cited by 121
ERα-associated translocations underlie oncogene amplifications in breast cancer
Lee, J. J.-K., Jung, Y. L., Cheong, T.-C., Valle-Inclán, J. E., Chu, C., Gulhan, D., Ljungström, V., Jin, H., Viswanadham, V., Watson, E. V., et al. (2023) · Nature · doi:10.1038/s41586-023-06057-w · Cited by 125
Self-citationStarrett, G. J., Marcelus, C., Cantalupo, P. G., Katz, J. P., Cheng, J., Akagi, K., Thakuria, M., Rabinowits, G., Wang, L. C., Symer, D. E., et al. (2017) · mBio · doi:10.1128/mbio.02079-16 · Cited by 126
Heterochromatin-Encoded Satellite RNAs Induce Breast Cancer
Zhu, Q., Hoong, N., Aslanian, A., Hara, T., Benner, C. W., Heinz, S., Miga, K. H., Ke, E., Verma, S. K., Soroczynski, J., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.04.023 · Cited by 121
Adam, S., Rossi, S. E., Moatti, N., De Marco Zompit, M., Xue, Y., Ng, T. F., Álvarez-Quilón, A., Desjardins, J., Bhaskaran, V., Martino, G., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00266-w · Cited by 121
Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer Therapies
Prince, E., Kheiri, S., Wang, Y., Xu, F., Cruickshank, J., Topolskaia, V., Tao, H., Young, E. W. K., McGuigan, A. P., Cescon, D. W., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202101085 · Cited by 121
Computational analysis of cancer genome sequencing data
Cortés‐Ciriano, I., Gulhan, D., Lee, J. J.-K., Melloni, G. E. M., & Park, P. J. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00431-y · Cited by 118
Self-citationPage, K., Guttery, D. S., Fernández-García, D., Hills, A., Hastings, R. K., Luo, J., Goddard, K. S., Shahin, V., Woodley-Barker, L., Rosales, B. M., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.261834 · Cited by 123
In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data
Celebi, R., Bear Don’t Walk, O., Movva, R., Alpsoy, S., & Dumontier, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-45236-6 · Cited by 120
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin
Arena, S., Corti, G., Durinikova, E., Montone, M., Reilly, N. M., Russo, M., Lorenzato, A., Arcella, P., Lazzari, L., Rospo, G., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2409 · Cited by 115
APOBEC3A is a prominent cytidine deaminase in breast cancer
Cortez, L. M., Brown, A. L., Dennis, M. A., Collins, C. D., Brown, A. J., Mitchell, D., Mertz, T. M., & Roberts, S. A. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008545 · Cited by 115
Mutagenesis by Microbe: the Role of the Microbiota in Shaping the Cancer Genome
Barrett, M., Hand, C. K., Shanahan, F., Murphy, T., & O’Toole, P. W. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.01.019 · Cited by 108
Portrait of a cancer: mutational signature analyses for cancer diagnostics
Van Hoeck, A., Tjoonk, N. H., van Boxtel, R., & Cuppen, E. (2019) · BMC Cancer · doi:10.1186/s12885-019-5677-2 · Cited by 107
Therapeutic landscape in mutational triple negative breast cancer
Shi, Y., Jin, J., Ji, W., & Guan, X. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0850-9 · Cited by 118
Pitt, J. J., Riester, M., Zheng, Y., Yoshimatsu, T. F., Sanni, A., Oluwasola, O., Veloso, A., Labrot, E., Wang, S., Odetunde, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06616-0 · Cited by 123
García‐Recio, S., Hinoue, T., Wheeler, G. L., Kelly, B., Garrido-Castro, A. C., Pascual, T., de Cubas, A. A., Xia, Y., Felsheim, B., McClure, M. B., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00491-x · Cited by 125
Self-citationWang, C., Yin, R. H., Dai, J., Gu, Y., Cui, S., Ma, H., Zhang, Z., Huang, J., Qin, N., Jiang, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04492-2 · Cited by 115
The effects of mutational processes and selection on driver mutations across cancer types
Temko, D., Tomlinson, I. P. M., Severini, S., Schuster-Böckler, B., & Graham, T. A. (2018) · Nature Communications · doi:10.1038/s41467-018-04208-6 · Cited by 115
The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer
Mattos‐Arruda, L. D., Sammut, S., Ross, E. M., Bashford-Rogers, R. J. M., Greenstein, E., Markus, H., Morganella, S., Teng, Y. H. F., Maruvka, Y. E., Pereira, B., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.098 · Cited by 117
Self-citationManjunath, M., & Choudhary, B. (2021) · Oncology Letters · doi:10.3892/ol.2021.12773 · Cited by 123
Pan-cancer analysis of whole genomesPreprint
Campbell, P. J., Getz, G., Stuart, J. M., Korbel, J. O., & Stein, L. D. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/162784 · Cited by 117
Self-citationGenetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases
Ng, C. K. Y., Bidard, F., Piscuoglio, S., Geyer, F. C., Lim, R. S., de Bruijn, I., Shen, R., Pareja, F. G., Berman, S., Wang, L., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3115 · Cited by 112
Self-citationNon-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers
Klinge, C. M. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0548 · Cited by 113
Pan, J. W., Zabidi, M. M. A., Ng, P.-S., Meng, M., Hasan, S. N., Sandey, B., Sammut, S., Yip, C. H., Rajadurai, P., Rueda, O. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20173-5 · Cited by 107
Self-citationMcVeigh, T. P., & Kerin, M. J. (2017) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s109847 · Cited by 112
A unified haplotype-based method for accurate and comprehensive variant calling
Cooke, D. P., Wedge, D. C., & Lunter, G. A. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00861-3 · Cited by 117
Self-citationJAK‐STAT core cancer pathway: An integrative cancer interactome analysis
Erdogan, F., Radu, T. B., Orlova, A., Qadree, A., de Araujo, E. D., Israelian, J., Valent, P., Mustjoki, S. M., Herling, M., Moriggl, R., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17228 · Cited by 111
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
Newell, F., Johansson, P. A., Wilmott, J. S., Nones, K., Lakis, V., Pritchard, A. L., Lo, S., Rawson, R. V., Kazakoff, S. H., Colebatch, A. J., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0603 · Cited by 119
MALAT1 long non-coding RNA and breast cancer
Arun, G., & Spector, D. L. (2019) · RNA Biology · doi:10.1080/15476286.2019.1592072 · Cited by 110
Smid, M., Rodríguez-González, F. G., Sieuwerts, A. M., Salgado, R., der Smissen, W. J. C. P., van der Vlugt‐Daane, M., van Galen, A., Nik‐Zainal, S., Staaf, J., Brinkman, A. B., et al. (2016) · Nature Communications · doi:10.1038/ncomms12910 · Cited by 105
Self-citationThe Origins and Vulnerabilities of Two Transmissible Cancers in Tasmanian Devils
Stammnitz, M. R., Coorens, T. H. H., Gori, K. C., Hayes, D., Fu, B., Wang, J., Martin-Herranz, D. E., Alexandrov, L. B., Baez‐Ortega, A., Barthorpe, S., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.013 · Cited by 107
Self-citationDe novo detection of somatic mutations in high-throughput single-cell profiling data sets
Muyas, F., Sauer, C. M., Valle-Inclán, J. E., Li, R., Rahbari, R., Mitchell, T. J., Hormoz, S., & Cortés‐Ciriano, I. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01863-z · Cited by 125
Patterns and mechanisms of structural variations in human cancer
Yi, K., & Ju, Y. S. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0112-3 · Cited by 108
Self-citationNones, K., Johnson, J., Newell, F., Patch, A. M., Thorne, H., Kazakoff, S. H., de Luca, X. M., Parsons, M. T., Ferguson, K., Reid, L. E., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz132 · Cited by 93
“In BC, 12 substitution and 6 structural rearrangement signatures were identified [9].”
InfluentialSelf-citationKazama, Y., Ishii, K., Hirano, T., Wakana, T., Yamada, M., Ohbu, S., & Abe, T. (2017) · The Plant Journal · doi:10.1111/tpj.13738 · Cited by 105
Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants
Wegert, J., Vokuhl, C., Collord, G., Velasco‐Herrera, M. D. C., Farndon, S. J., Guzzo, C., Jørgensen, M., Anderson, J., Slater, O., Duncan, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04650-6 · Cited by 105
Self-citationAn extended APOBEC3A mutation signature in cancer
Langenbucher, A., Bowen, D., Sakhtemani, R., Bournique, E., Wise, J. F., Zou, L., Bhagwat, A. S., Buisson, R., & Lawrence, M. S. (2021) · Nature Communications · doi:10.1038/s41467-021-21891-0 · Cited by 102
Bhatia, S., Kramer, M., Russo, S., Naik, P., Arun, G., Brophy, K., Andrews, P., Fan, C., Perou, C. M., Preall, J. B., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-2807 · Cited by 103
The circular RNome of primary breast cancer
Smid, M., Wilting, S. M., Uhr, K., Rodríguez-González, F. G., de Weerd, V., Prager-Van der Smissen, W. J. C., van der Vlugt-Daane, M., van Galen, A., Nik-Zainal, S., Butler, A., et al. (2019) · Genome Research · doi:10.1101/gr.238121.118 · Cited by 105
Self-citationPhenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications
Reed, A. E. M., Kalaw, E., Nones, K., Bettington, M. L., Lim, M., Bennett, J., Johnstone, K. J., Kutasovic, J. R., Saunus, J. M., Kazakoff, S. H., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5184 · Cited by 103
Self-citationHelm, J. S., & Rudel, R. A. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02752-z · Cited by 109
Salemme, V., Centonze, G., Avalle, L., Natalini, D., Piccolantonio, A., Arina, P., Morellato, A., Ala, U., Taverna, D., Turco, E., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1170264 · Cited by 106
Targeting DNA Replication Stress for Cancer Therapy
Zhang, J., Dai, Q., Park, D., & Deng, X. (2016) · Genes · doi:10.3390/genes7080051 · Cited by 102
Effects of short indels on protein structure and function in human genomes
Lin, M., Whitmire, S. M., Chen, J., Farrel, A., Shi, X. M., & Guo, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-09287-x · Cited by 109
Homologous Recombination and the Formation of Complex Genomic Rearrangements
Piazza, A., & Heyer, W. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.10.006 · Cited by 108
Zhu, H., Uusküla-Reimand, L., Isaev, K., Wadi, L., Alizada, A., Shuai, S., Huang, V., Aduluso-Nwaobasi, D., Paczkowska, M., Abd-Rabbo, D., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.12.027 · Cited by 100
Self-citationSztupinszki, Z. M., Dióssy, M., Krzystanek, M., Börcsök, J., Pomerantz, M. M., Tisza, V., Spisák, S., Rusz, O., Csabai, I., Freedman, M. L., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2135 · Cited by 100
Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency
Davies, H., Morganella, S., Purdie, C. A., Jang, S. J., Borgen, E., Russnes, H., Glodzik, D., Zou, X., Viari, A., Richardson, A. L., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1083 · Cited by 99
Self-citationQuantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots
Jalili, P. R., Bowen, D., Langenbucher, A., Park, S., Aguirre, K., Corcoran, R. B., Fleischman, A. G., Lawrence, M. S., Zou, L., & Buisson, R. (2020) · Nature Communications · doi:10.1038/s41467-020-16802-8 · Cited by 101
Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy
Marra, A., & Curigliano, G. (2021) · The Cancer Journal · doi:10.1097/ppo.0000000000000498 · Cited by 102
de Jong, V. M. T., Wang, Y., ter Hoeve, N. D., Opdam, M., Stathonikos, N., Jóźwiak, K., Hauptmann, M., Cornelissen, S., Vreuls, W., Rosenberg, E. H., et al. (2022) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-217984 · Cited by 100
Self-citationThatikonda, V., Islam, S. M. A., Autry, R. J., Jones, B. C., Gröbner, S. N., Warsow, G., Hutter, B., Hüebschmann, D., Fröhling, S., Kool, M., et al. (2023) · Nature Cancer · doi:10.1038/s43018-022-00509-4 · Cited by 100
Self-citationDetecting presence of mutational signatures in cancer with confidence
Huang, X., Wójtowicz, D., & Przytycka, T. M. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx604 · Cited by 99
Cortés‐Ciriano, I., Steele, C. D., Piculell, K., Al‐Ibraheemi, A., Eulo, V. A., Bui, M. M., Chatzipli, A., Dickson, B. C., Borcherding, D. C., Feber, A., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0786 · Cited by 116
Kim, J., Geyer, F. C., Martelotto, L. G., Ng, C. K. Y., Lim, R. S., Selenica, P., Li, A., Pareja, F. G., Fusco, N., Edelweiss, M., et al. (2017) · The Journal of Pathology · doi:10.1002/path.5006 · Cited by 98
Self-citationNeurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer
Zheng, Z.-Y., Anurag, M., Lei, J. T., Cao, J., Singh, P., Peng, J., Kennedy, H., Nguyen, N.-C., Chen, Y., Lavere, P. F., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.02.003 · Cited by 99
Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines
Papp, E., Hallberg, D. L., Konecny, G. E., Bruhm, D. C., Adleff, V., Noë, M., Kagiampakis, I., Palsgrove, D. N., Conklin, D. F., Kinose, Y., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.096 · Cited by 97
Chen, T., Leng, J., Tan, J., Zhao, Y., Xie, S., Zhao, S., Yan, X., Zhu, L., Luo, J., Kong, L., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00967 · Cited by 102
ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer
Tu, X., Kahila, M. M. H., Zhou, Q., Yu, J., Kalari, K. R., Wang, L., Harmsen, W. S., Yuan, J., Boughey, J. C., Goetz, M. P., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0470 · Cited by 100
Patel, S. K., George, B., & Rai, V. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01177 · Cited by 102
Structural Variation in Cancer: Role, Prevalence, and Mechanisms
Cosenza, M. R., Rodríguez–Martín, B., & Korbel, J. O. (2022) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-120121-101149 · Cited by 99
sigfit: flexible Bayesian inference of mutational signaturesPreprint
Gori, K. C., & Baez‐Ortega, A. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/372896 · Cited by 91
Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer
Jager, M., Blokzijl, F., Kuijk, E., Bertl, J., Vougioukalaki, M., Janssen, R., Besselink, N., Boymans, S., de Ligt, J., Pedersen, J. S., et al. (2019) · Genome Research · doi:10.1101/gr.246223.118 · Cited by 98
Estrogen receptor signaling is reprogrammed during breast tumorigenesis
Chi, D., Singhal, H., Li, L., Xiao, T., Liu, W., Pun, M. J., Jeselsohn, R. M., He, H., Lim, E., Vadhi, R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819155116 · Cited by 94
DNA Damage and Its Role in Cancer Therapeutics
Moon, J., Kitty, I., Renata, K., Qin, S., Zhao, F., & Kim, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054741 · Cited by 100
Multiomics technologies: role in disease biomarker discoveries and therapeutics
Dar, M. A., Arafah, A. M., Bhat, K. A., Khan, A., Khan, M. S., Ali, A., Ahmad, S. M., Rashid, S. M., & Rehman, M. U. (2022) · Briefings in Functional Genomics · doi:10.1093/bfgp/elac017 · Cited by 102
Chen, H., Deng, C., Gao, J., Wang, J., Fu, F., Wang, Q., Wang, Q., Zhang, S., Zhang, S., Fan, F., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.01.012 · Cited by 98
Self-citationHuman papillomavirus 16 promotes microhomology-mediated end-joining
Leeman, J. E., Li, Y., Bell, A., Hussain, S. S., Majumdar, R., Rong, X., Blecua, P., Damerla, R. R., Narang, H., Ravindran, P. T., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906120116 · Cited by 92
Self-citationReliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity
Shi, W., Ng, C. K. Y., Lim, R. S., Jiang, T., Kumar, S., Li, X., Wali, V. B., Piscuoglio, S., Gerstein, M., Chagpar, A. B., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.046 · Cited by 92
Glodzik, D., Morganella, S., Davies, H., Simpson, P. T., Li, Y., Zou, X., Diez-Perez, J., Staaf, J., Alexandrov, L. B., Smid, M., et al. (2017) · Nature Genetics · doi:10.1038/ng.3771 · Cited by 84
Self-citationGhoreyshi, N., Heidari, R., Farhadi, A., Chamanara, M., Farahani, N., Vahidi, M., & Behroozi, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-01816-9 · Cited by 91
Lee, J., Lee, A., Lee, J., Park, J., Kwon, Y., Park, S., Chun, H., Ju, Y., & Hong, D. (2018) · Nucleic Acids Res. · doi:10.1093/nar/gky406 · Cited by 84
Self-citationThe germline mutational landscape of BRCA1 and BRCA2 in Brazil
Palmero, E. I., Carraro, D. M., Alemar, B., Moreira, M. A. M., Ribeiro‐dos‐Santos, Â., Abe‐Sandes, K., Galvão, H. C. R., Reis, R. M., Souza, C. D. P., Campacci, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27315-2 · Cited by 91
Li, Q., Guan, X., Chen, S., Yi, Z., Lan, B., Xing, P., Fan, Y., Wang, J., Luo, Y., Yuan, P., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4173 · Cited by 91
Genome-wide mapping of somatic mutation rates uncovers drivers of cancer
Sherman, M. A., Yaari, A. U., Priebe, O., Dietlein, F., Loh, P.-R., & Berger, B. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01353-8 · Cited by 80
Metadata
- Authors
- Nik-Zainal, S., Davies, H., Staaf, J., Ramakrishna, M., Glodzik, D., Zou, X., Martincorena, I., Alexandrov, L. B., Martin, S., Wedge, D. C., Van Loo, P., Ju, Y. S., Smid, M., Brinkman, A. B., Morganella, S., Aure, M. R., Lingjærde, O. C., Langerød, A., Ringnér, M., Ahn, S.-M., Boyault, S., Brock, J. E., Broeks, A., Butler, A., Desmedt, C., Dirix, L., Dronov, S., Fatima, A., Foekens, J. A., Gerstung, M., Hooijer, G. K. J., Jang, S. J., Jones, D. R., Kim, H.-Y., King, T. A., Krishnamurthy, S., Lee, H. J., Lee, J.-Y., Li, Y., McLaren, S., Menzies, A., Mustonen, V., O’Meara, S., Pauporté, I., Pivot, X., Purdie, C. A., Raine, K., Ramakrishnan, K., Rodríguez-González, F. G., Romieu, G., Sieuwerts, A. M., Simpson, P. T., Shepherd, R., Stebbings, L., Stefansson, O. A., Teague, J., Tommasi, S., Treilleux, I., Van den Eynden, G. G., Vermeulen, P., Vincent-Salomon, A., Yates, L., Caldas, C., Veer, L. V., Tutt, A., Knappskog, S., Tan, B. K. T., Jonkers, J., Borg, Å., Ueno, N. T., Sotiriou, C., Viari, A., Futreal, P. A., Campbell, P. J., Span, P. N., Van Laere, S., Lakhani, S. R., Eyfjord, J. E., Thompson, A. M., Birney, E., Stunnenberg, H. G., van de Vijver, M. J., Martens, J. W. M., Børresen-Dale, A.-L., Richardson, A. L., Kong, G., Thomas, G., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- Lund University (SE)
- Los Alamos National Laboratory (US)
- Erasmus MC (NL)
- Radboud University Nijmegen (NL)
- European Bioinformatics Institute (GB)
- Oslo University Hospital (NO)
- University of Oslo (NO)
- Gachon University Gil Medical Center (KR)
- Centre Léon Bérard (FR)
- Brigham and Women's Hospital (US)
- The Netherlands Cancer Institute (NL)
- Université Libre de Bruxelles (BE)
- University of Antwerp (BE)
- Dana-Farber Cancer Institute (US)
- Amsterdam UMC Location University of Amsterdam (NL)
- Asan Medical Center (KR)
- Hanyang University (KR)
- Memorial Sloan Kettering Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Institut National du Cancer (FR)
- Inserm (FR)
- Ninewells Hospital (GB)
- Institut Regional du Cancer de Montpellier (FR)
- The University of Queensland (AU)
- Istituto Tumori Bari (IT)
- University of Cambridge (GB)
- Institute of Cancer Research (GB)
- Haukeland University Hospital (NO)
- Singapore General Hospital (SG)
- Institut national de recherche en sciences et technologies du numérique (FR)
- Radboud University Medical Center (NL)
- University of Iceland (IS)
- Corresponding author
- Viari, Alain
- Kong, Gu
- Stratton, Michael R.
- ORCID
- Davies, Helen
- Staaf, Johan
- Ramakrishna, Manasa
- Zou, Xueqing
- Alexandrov, Ludmil B.
- Martin, Sancha
- Wedge, David C.
- Ju, Young Seok
- Smid, Marcel
- Brinkman, Arie B.
- Morganella, Sandro
- Aure, Miriam R.
- Lingjærde, Ole Christian
- Ringnér, Markus
- Ahn, Sung-Min
- Boyault, Sandrine
- Brock, Jane E.
- Broeks, Annegien
- Desmedt, Christine
- Dirix, Luc
- Dronov, Serge
- Gerstung, Moritz
- Hooijer, Gerrit K. J.
- Jang, Se Jin
- Jones, David R.
- Krishnamurthy, Savitri
- Lee, Hee Jin
- Lee, Jeong-Yeon
- Li, Yilong
- McLaren, Stuart
- Menzies, Andrew
- Mustonen, Ville
- Pivot, Xavier
- Purdie, Colin A.
- Raine, Keiran
- Ramakrishnan, Kamna
- Rodríguez-González, F. Germán
- Sieuwerts, Anieta M.
- Simpson, Peter T.
- Shepherd, Rebecca
- Teague, Jon
- Tommasi, Stefania
- Treilleux, Isabelle
- Vermeulen, Peter
- Yates, Lucy
- Caldas, Carlos
- Veer, Laura van’t
- Tutt, Andrew
- Knappskog, Stian
- Tan, Benita Kiat Tee
- Jonkers, Jos
- Borg, Åke
- Ueno, Naoto T.
- Sotiriou, Christos
- Viari, Alain
- Futreal, P. Andrew
- Span, Paul N.
- Lakhani, Sunil R.
- Thompson, Alastair M.
- Birney, Ewan
- Stunnenberg, Hendrik G.
- Martens, John W. M.
- Richardson, Andrea L.
- Kong, Gu
- Thomas, Gilles
- Stratton, Michael R.
- Venue
- Nature
- Published
- 2016-05-02
- Volume
- 534
- Issue
- 7605
- Pages
- 47-54
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4910866
- OpenAlex
- W2344657883
- Semantic Scholar
- abb27e35f11dcd60325f42f270b7811a4e852852
- Cited by
- 2,218
- References
- 60
- Citations by year
- 2026: 125 · 2025: 147 · 2024: 178 · 2023: 271 · 2022: 212 · 2021: 293 · 2020: 288 · 2019: 241 · 2018: 200 · 2017: 181 · 2016: 78
- FWCI
- 97.22
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-01-18)
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- PubMed Central (acceptedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Apollo
- Funders
- U.S. Department of Energy (DE-AC52-06NA2-5396, AC52-06NA25396)
- Breast Cancer Research Foundation
- Dana-Farber/Harvard Cancer Center (P50 CA168504)
- University of Dundee
- Wellcome Trust (088177, 077012/Z/05/Z, 100183, 077012, WT100183MA, 098051)
- Francis Crick Institute (10202)
- QIMR Berghofer Medical Research Institute
- Cancer Research UK (60098573, 20952, CB4140, 16942)
- National Institute for Health and Care Research (NF-SI-0515-10090, NF-SI-0611-10154)
- Breast Cancer Campaign
- University of Cambridge
- European Commission (242006)
- National Research Foundation
- Icelandic Centre for Research
- Fonds De La Recherche Scientifique - FNRS
- Cancerfonden
- Cambridge University Hospitals (RG51913)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- National Research Foundation of Korea (2015R1A2A1A10052578, 2011-0030105)
- Vetenskapsrådet
- Háskóli Íslands
- Institut National Du Cancer
- Rannís
- National Institutes of Health (DE-AC52-06NA25396)
- National Nuclear Security Administration (DEAC52- 06NA25396)
- National Cancer Institute (CA168504, P30CA008748, P50CA168504)
- Los Alamos National Laboratory (AC52-06NA25396, DE-AC52-06NA25396)
- FP7 Ideas: European Research Council (322737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- breast cancer, somatic mutations, driver mutations, mutational signatures, tandem duplication, homologous recombination deficiency, BRCA1, BRCA2, non-coding regions, intronic variants
- MeSH terms
- Breast Neoplasms, DNA Mutational Analysis, DNA Replication, DNA, Neoplasm, Female, Humans, Male, Mutation, Oncogenes, Cohort Studies, Genome, Human, Mutagenesis, Genes, BRCA1, Genomics, Genes, BRCA2, Mutation Rate, Recombinational DNA Repair
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
